Partner news
News
Partner news
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read full storyPartner news
HistoSonics Announces $40 Million Financing
Read full storyPartner news
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression
Read full storyPartner news
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science
Read full storyPartner news
Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Read full storyPartner news
E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders
Read full storyPartner news
Israel's Zebra Medical Vision raises $30 million
Read full storyPartner news
BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist
Read full storyPartner news
Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease
Read full storyPartner news
ReVision Optics Receives FDA Approval for the Raindrop® Near Vision Inlay
Read full storyPartner news
Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing
Read full storyPartner news